Objectives: To develop a rapid method for routine screening of methicillin-resistant staphylococci and VRE for clinical isolates and positive blood cultures.
Introduction
Antibiotic resistance is a ceaseless challenge to medical systems worldwide. Early detection of resistant aetiological agents and hence timely prescription of appropriate antibiotics have been shown to correlate with better clinical outcome. 1, 2 Clinical microbiology laboratories play a pivotal role in this aspect. The 'boom' of molecular diagnostic techniques in the past 30 years has revolutionized traditional culture-based approaches of pathogen detection. Ideally, the identities and antibiotic resistance traits of aetiological agents are detected directly from clinical specimens with a short turnaround time. 3, 4 To fit into busy laboratory schedules, commercial molecular detection assays are designed to be highly automated with minimal hands-on time, and this convenience is reflected on the cost per reaction, rendering these tests performed mostly on an ad hoc basis. In addition, the narrow specimen variety and throughput also limit the use of these state-of-the-art methods for mass screening purposes.
In light of this, we tailored a robust yet economical method for routine screening of antibiotic-resistant bacteria, initially focusing on methicillin-resistant staphylococci (MRS) and VRE. Our method combined the species-discriminating power of MALDI-TOF MS and the multiplex capability of real-time PCR -melt curve analysis (MCA). The screening targets included clinical isolates and positive blood cultures.
Materials and methods

Procedure overview
Our method was eligible for both clinical isolates and positive blood cultures and consisted of two parts. First, MALDI-TOF MS was used for screening suspected clinical isolates or positive blood cultures. If Staphylococcus or Enterococcus species were identified, the same sample would be subjected to real-time PCR -MCA for the detection of related antibiotic resistance/cytotoxin genes, including mecA, mecA LGA251 and Panton-Valentine leucocidin (PVL) genes in a triplex reaction for staphylococcal culture isolates, dual PCR of mecA/mecA LGA251 and nuc genes for staphylococcal blood cultures, and vanA and vanB genes in a duplex reaction for enterococci. A schematic workflow is shown in Figure 1 . The total assay time was ,2.5 h. 
Positive control strains
Clinical strains
A total of 124 clinical isolates and 56 positive blood cultures were tested. For clinical isolates, 86 were isolated from pure cultures retrieved from Microbank cryovials (Pro-Lab Diagnostics, Richmond Hill, Canada), whereas 38 were isolated from primary culture plates which were mostly mixed with other bacterial species. As the number of positive blood cultures was insufficient (n ¼ 3), 53 mimicked samples were prepared for testing their inhibitory effect on the assay. The details of these strains are summarized in Table 1 . The antibiotic susceptibility patterns of these isolates were well characterized with reference to guidelines recommended by the CLSI. The presence of the PVL gene in these isolates was confirmed by a local reference laboratory (Public Health Laboratory Services Branch, Centre for Health Protection, Department of Health, Hong Kong, China) or in-house PVL PCR. The presence of vanA or vanB genes was confirmed by Xpert w vanA/vanB or the corresponding laboratories listed in Table 1 .
Retrieval of cryopreserved strains and preparation of mimicked positive blood cultures
The Microbank strains were retrieved from cryovials, inoculated onto Columbia agar supplemented with 5% sheep blood (Oxoid, Cambridge, UK) and then incubated overnight at 358C and 5% CO 2 . To prepare mimicked positive blood cultures, 0.5 mL of bacterial suspension (0.5 McFarland) was spiked into leftover negative blood culture vials followed by overnight incubation at 358C.
Specimen selection criteria
For primary culture plates, all E. faecium/Enterococcus faecalis (VRE screening cases only) and Staphylococcus aureus colonies were tested. Discrete colonies were picked from areas with scanty growth of bacteria. The respective top 10 MALDI-TOF MS classification results should belong to the same species, with the highest identification score ≥2.0. For species with reference mass spectrum profiles (MSPs) ,10, the scores of all their MSPs should be higher than that of other species in the list, and the scores of other species should be ,1.7.
Mimicked positive blood cultures were prepared with single MRSA or VRE species or combinations of MSSA and methicillin-resistant CoNS (MRCoNS). In routine practice, a preliminary MS identification report will not be issued unless: (i) the highest identification score of the species is ≥2.0; and (ii) the highest identification score of the second species, if any, is ,1.6. For bacterial colonies on primary culture plates, a minute amount of isolate was picked with a sterile pipette tip and resuspended in 10 mL of ddH 2 O. A 2 mL aliquot of this suspension was placed on the target plate, air dried and covered with 1 mL of absolute formic acid (Sigma-Aldrich, St Louis, MA, USA). Each dried spot was then covered with 1 mL of 10 mg/mL matrix solution (a-cyano-4-hydroxycinnamic acid, Bruker Daltonik, Bremen, Germany). The dried samples were then subjected to MS measurement after successful calibration with Bacterial Test Standard (Bruker Daltonik, Bremen, Germany). For positive blood cultures, a Sepsityper Kit TM (Bruker Daltonik, Bremen, Germany) was used according to the manufacturer's instructions.
Bacterial identification by MALDI-TOF MS
Real-time PCR -MCA
Three sets of PCR were used in this study, namely mecA/mecA LGA251 /PVL triplex PCR for staphylococcal culture isolates, dual PCR of mecA/ mecA LGA251 and nuc genes for staphylococcal blood cultures, and vanA/ vanB duplex PCR for enterococci. The primer sequences are shown in Table 2 . Besides mecA LGA251 and nuc primer pairs and the reverse primer for the PVL gene, all primers were designed by aligning sequences retrieved from the GenBank database of the National Center for Biotechnology Information (NCBI) using the ClustalW alignment tool of Molecular Evolutionary Genetics Analysis software version 4.0. 5 The specificity of the primers was evaluated by using the NCBI Basic Local Alignment Search Tool.
For isolates from primary culture plates, 1 mL of bacterial suspension (the same suspension as for MALDI-TOF MS) was used as DNA template. For positive blood cultures, the quick method described by Adams 6 was MALDI-TOF MS and MCA for rapid identification of methicillin-resistant staphylococci and VRE 443 JAC adopted. Briefly, four drops of blood culture broth were added to 4 mL of ddH 2 O and 1 mL of this suspension was used as DNA template. The 24 mL working master mixture contained 12.5 mL of 2X Type-it HRM PCR Master Mix (Qiagen, Hilden, Germany), 0.4 mM (final concentration) of each primer (Tech Dragon Ltd, Hong Kong, China) and an appropriate volume of ddH 2 O. Real-time PCR -MCA was performed using Rotor-Gene Q (Qiagen, Hilden, Germany) with the following conditions: initial cell lysis and denaturation at 958C for 10 min; three step cycling for 40 times (958C for 10 s, 558C for 30 s and 728C for 15 s); and MCA settings of a ramp from 70 to 908C, rising by 0.18C in each step. Derivative melt curves (dF/dT versus T m ) were generated automatically by using the 'Melt' function of the program. The dF/dT threshold was set at 0.5 arbitrary units. The threshold cycle (Ct) of each amplification reaction (staphylococcal blood cultures only) was determined by using the 'Quantitation' tool of the program. Samples with cycle numbers ≤38 and correct T m values were considered as PCR-positive.
Result interpretation
The result interpretation guidelines are shown in Figure 2 . For positive blood cultures, the interpretation of results was more conservative due to limited information on the potential presence of coexistent staphylococcal/enterococcal species (i.e. mixed blood cultures). All preliminary results generated by this rapid method were confirmed by conventional bacterial culture and antibiotic susceptibility testing.
Results and discussion
Initially, positive control strains were tested to determine the preliminary T m value of each target amplicon. Duplicate samples were tested in three individual runs. Gel electrophoresis confirmed that the amplicons were of expected sizes. The mean T m value, standard deviation (SD) and coefficient of variation (CV), respectively, were as follows: mecA LGA251 , 76.408C, 0.07 and 0.10%; mecA, 77.438C, 0.03 and 0.04%; nuc, 79.028C, 0.08 and 0.1%; PVL, 78.428C, 0.07 and 0.001%; vanA, 82.688C, 0.06 and 0.07%; and vanB, 84.258C, 0.10 and 0.12%. As the melt curves of these amplicons were well separated from each other (Figure 3) , the same assay conditions were applied on clinical isolates and positive blood cultures. A total of 124 clinical isolates and 56 positive blood cultures were screened.
The results revealed 100% concordance (140/140) with antibiotic susceptibility patterns and genotypes determined by reference methods for all culture isolates and enterococcal blood cultures. The degree of PCR inhibition was 0% (0/145). The mean T m value, SD and CV, respectively, including the results of clinical samples, were as follows: mecA, 77.458C, 0.14 and 0.18% (n ¼ 98); nuc, 79.098C, 0.16 and 0.2% (n ¼ 40); PVL, 78.378C, 0.06 and 0.08% (n ¼ 33); vanA, 82.688C, 0.07 and 0.08% (n ¼ 46); and vanB, 84.498C, 0.26 and 0.30% (n ¼ 6). mecA LGA251 data were not available due to the lack of mecA LGA251 -positive clinical strains in our laboratory, though the primer specificity was well evaluated by Stegger et al. 7 In general, these amplicons displayed reproducible T m values, whilst those of vanB amplicons showed minor variation (84.12 -84.788C). The variations in genotype and GC content might account for this. 9, 10 As a proof of concept, the amplicons of vanB-positive control ATCC w 51299 TM (T m : 84.258C) and the two vanB-positive vancomycin-resistant E. faecium clinical strains (T m : 84.71 and 84.748C) were sequenced. The GC contents were 48.3%, 49.7% and 49.8%, respectively. The lower GC content of the ATCC w 51299 TM amplicon might account for its lower T m value. Further analysis of sequence data confirmed that ATCC w 51299 TM contained vanB1 whereas the two clinical strains possessed vanB2 elements. The data demonstrated the potential of this assay for distinguishing between vanB1 and vanB2 genotypes, which requires further evaluation with more clinical isolates. In addition, no false-positive signal was detected for the three vancomycinintermediate Enterococcus gallinarum isolates, whose intrinsic resistance to glycopeptides is usually contributed by the VanC phenotype. 11, 12 One challenge for the molecular detection of transmissible antibiotic resistance genes is the possession of such genes by other non-target microbes in polymicrobial samples, resulting in false-positive signals. For instance, the mecA gene can be found MSCoNS, methicillin-susceptible CoNS; VSE, vancomycin-susceptible enterococci; |ΔCt|, difference in threshold cycle between mecA/mecA LGA251 and nuc amplification reactions (absolute value).
a All preliminary results should be confirmed by conventional method.
b The presence of MSCoNS could not be excluded. Figure 2 . Result interpretation guidelines. MALDI-TOF MS and MCA for rapid identification of methicillin-resistant staphylococci and VRE 445 JAC in MRCoNS and the presence of the vanB gene in various bacterial species has been reported, e.g. in Streptococcus and Clostridium species. 13 Whilst the latter is more likely to be present in stool samples than in positive blood cultures, the coexistence of MSSA and MRCoNS is not uncommon in positive blood cultures. In this study, we attempted to minimize this false positivity by finetuning the protocol and result interpretation guidelines.
Culture isolates
Despite the strong microbial identification power of MALDI-TOF MS, its species-resolving capability for polymicrobial blood cultures is not satisfactory. Previous evaluation studies demonstrated that identification was confined to single microbial species for a majority of polymicrobial blood cultures. 13 -15 In this study, only 20% of bistaphylococcal blood cultures were correctly identified (Table 3 ). This phenomenon may be interpreted from two facets. First, each reference spectrum from the MSP library was created with single microbial species. With a reduced number of detectable peaks due to lower microbial concentration, 16 the minority microbial species is usually 'overlooked' by spectra-matching algorithms, leading to the identification of dominant species only. Second, even if the concentrations of two microbes are comparable, the preference of the spectramatching may not be equivalent. This is especially prominent for closely related species with similar MS spectra, e.g. our data revealed that S. aureus was preferentially identified compared with other CoNS in bistaphylococcal blood cultures (Table 3) . This phenomenon may also be contributed by the relative abundance and quality of reference spectra in the MSP library. In short, MALDI-TOF MS provides us with a general idea on the dominant microbial species in a polymicrobial blood culture sample, yet with limited information on residual microbial species. Despite this limitation, MS results provide crucial direction for the molecular detection of antibiotic resistance and subsequent result interpretation.
In the past decade, much effort has been devoted to circumvent false MRSA-positive amplification signals due to coexistence of MSSA and MRCoNS in polymicrobial samples. These strategies can be generally divided into two approaches, namely (i) the detection of the staphylococcal cassette chromosome mec (SCCmec)-orfX junction, and (ii) the difference in threshold cycle (DCt) between the amplification of S. aureus-specific genomic sequence and the mecA gene. As the sequence diversity of SCCmec complicates primer design and subsequent T m analysis, the latter approach was adopted in this study. Staphylococcal blood cultures were subject to two sets of PCR, namely (i) the amplification of mecA and mecA LGA251 genes, which are the genetic determinants of methicillin resistance, and (ii) the amplification of the nuc gene, which encodes a thermostable nuclease of S. aureus. As these genes share the same copy number in the We have demonstrated the complementary use of MALDI-TOF MS and real-time PCR-MCA for routine screening of MRS and VRE. Our method was rapid (,2.5 h), economical (,2 GBP), reliable (100% concordance for all culture isolates and enterococcal blood cultures; 97.5% concordance for staphylococcal blood cultures and 0% inhibition) and convenient (DNA extraction was not required). The species identification power of MALDI-TOF MS allowed accurate identification of Staphylococcus and Enterococcus species. The multiplex capability of real-time PCR -MCA allowed simultaneous detection of multiple clinically significant antibiotic resistance/cytotoxin genes. Upon careful design of primers and optimization of assay conditions, this in-house method could be adjusted for the detection of emerging antibiotic resistance/ virulence-associated genes. Our method was especially useful for mixed bacterial cultures in which the amount of target organism is insufficient for rapid susceptibility assay. Before the maturation of emerging rapid susceptibility testing technologies, the molecular detection of antibiotic resistance genes will continue to provide timely information for appropriate prescription and infection control measures.
Conclusions
We have demonstrated that the complementary use of MALDI-TOF MS and real-time PCR -MCA is feasible for routine screening of MRS and VRE. Future large-scale testing is required to further evaluate the performance of this method and streamline the procedure for routine use.
